Glucose profiles in a type I diabetic patient successively treated with CSII using regular insulin, lispro and an implantable insulin pump

Diabetes and Metabolism

Volumn 26, Issue 3, 2000, Pages 210-214

  Catargi, B ^a   Breilh, D ^a   Roger, P ^a   Tabarin, A ^a  

^a HAUT LÉVÊQUE HOSPITAL   (France)

Author keywords

Continuous subcutaneous insulin infusion; Implantable insulin pump; Lispro

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HUMAN INSULIN; INSULIN ANTIBODY; INSULIN LISPRO; NEUTRAL INSULIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; CASE REPORT; DIABETES CONTROL; DRUG ABSORPTION; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN PUMP; MALE;

ADULT; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MALE;

EID: 0033947247     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. The DCCT Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med, 1993, 329, 977-986.
2. Kraegen EW, Chisholm DJ. Pharmacokinetics of insulin. Implications for continuous subcutaneous insulin infusion therapy. Clin Pharmacokin, 1985, 10, 303-314.
3. Lauritzen T, Pramming S, Deckert T, Binder C. Pharmacokinetics of continuous subcutaneous insulin infusion. Diabetologia, 1983, 24, 326-329.
4. Bode BW, Steed RD, Davidson PC. Reduction in severe hypoglycemia with long-term continuous insulin infusion in type I diabetes. Diabetes Care, 1996, 19, 324-327.
5. Hildebrandt P, Birch K, Jensen BM, Kühl C. Subcutaneous insulin infusion: change in basal infusion rate has no immediate effect on insulin absorption rate. Diabetes Care, 1986, 9, 561-564.
6. Gardner DF, Arakaki RF, Podet EJ, Nell LJ, Thomas JW, Field JB. The pharmakokinetics of subcutaneous regular insulin in type I diabetic patients: assessement using a glucose clamp technique. J Clin Endocrinol Metab, 1986, 63, 689-694.
7. Zinman B, Tildesley H, Chiasson JL, Tsui E, Strack T. Insulin lispro in CSII. Results of a double-blind crossover study. Diabetes, 1997, 46, 440-443.
8. Melki V, Renard E, Lassman-Vague V, et al. Improvement of HbAlc and blood glucose stability in IDDM patients treated with lispro insulin analog in external pumps. Diabetes Care, 1998, 21, 977-982.
9. Nathan DM, Dunn FL, Bruch J, et al. Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent mellitus patients. Am J Med. 1996, 100, 412-417.
10. Saudek CD, Selam JL, Pitt HA, Waxman K, et al. A preliminary trial of the programmable implantable medication system for insulin delivery. N Engl J Med, 1989, 321, 574-579.
11. Kovatchev BP, Cox JD, Gonder-Frederick LA, Clarke W. Symmetrisation of the blood glucose measurement scale and its applications. Diabetes Care, 1997, 20, 1655-1658.
12. Kovatchev BP, Cox JD, Gonder-Frederick LA, Young-Hyman D, Schlundt D, Clarke W. Assessement of risk for severe hypoglycemia among adults with IDDM. Diabetes Care, 1998, 21, 1870-1875.
13. Service FJ, Nelson RL. Characteristics of glycemic stability. Diabetes Care, 1980, 3, 58-63.
14. Selam JL. Implantable insulin pumps. Lancet, 1999, 359, 178-179.
15. Nelson JA, Stephen R, Landau ST, Wilson DE, Tyler FH. Intraperitoneal insulin administration produces a positive portal systemic blood insulin gradient in unanesthezied unrestrained swine. Metabolism, 1982, 31, 969-972.
16. Cox JD, Kovatchev BP, Julian DM, Gonder-Frederick LA, Polonsky WH, Schlundt DG, Clarke WL. Frequency of severe hypoglycemia in insulin-dependent diabetes mellitus can be predicted from self-monitoring blood glucose data. J Clin Endocrinol Metab, 1994, 79, 1659-1662.
17. Broussolle C, Jeandidier N, Hanaire-Broutin H, et al. French multicenter experience of implantable insulin pumps. Lancet, 1994, 343, 514-515.
18. Jeandidier N, Selam JL, Renard E, et al. Decreased severe hypoglycemia frequency during intraperitoneal insulin infusion using programmable implantable pumps. Diabetes Care, 1996, 19, 780.
19. Hanaire-Broutin HCB, Jeandidier N, et al. Feasibility of intraperitoneal insulin therapy with programmable implantable pumps in IDDM: a multicenter study. Diabetes Care, 1995, 18, 388-392.